Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study
Harindra Rajasekeran(University of Toronto), David Z.I. Cherney(University Health Network), Bridgit B. Bowskill(St. Michael's Hospital), Syamantak Majumder(St. Michael's Hospital), Ian W. Gibson(University of Manitoba), Manish M. Sood(Ottawa Hospital), Petter Bjornstad(University of Colorado Denver), Heather N. Reich(University Health Network), Leslie Cham(University Health Network), Vesta Lai(University Health Network), Andrew Advani(St. Michael's Hospital), Yuliya Lytvyn(University Health Network), Suzanne L. Advani(St. Michael's Hospital), Julie A. Lovshin(Sunnybrook Health Science Centre), Daniel C. Cattran(Toronto Rehabilitation Institute), Michelle Hladunewich(Sunnybrook Health Science Centre), M. Golam Kabir(University of Toronto), Josephine Tse(University Health Network)
Cited by 87
Related Papers
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions
|American Journal of Transplantation|2008|1.9k
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
|Kidney International|2009|1.2k